Compounds are provided of the following structure are HMG CoA reductase inhibitors and thus are active in inhibiting cholesterol biosynthesis, modulating blood serum lipids, for example, lowering LDL cholesterol and/or increasing HDL cholesterol, and treating hyperlipidemia and dyslipidemia, hypercholesterolemia, hypertriglyceridemia and atherosclerosis
wherein A is chosen from
B is chosen from
wherein the variables R
1
to R
7
, m, n,
are as defined herein.
A method for treating the above diseases employing the above compounds is also provided.
提供以下结构的化合物是
HMG CoA还原酶
抑制剂,因此在抑制
胆固醇生物合成、调节血清脂质,例如降低LDL
胆固醇和/或增加HDL
胆固醇,以及治疗高脂蛋白血症和血脂异常、高
胆固醇血症、高
甘油三酯血症和动脉粥样硬化方面具有活性。
其中A选择自
B选择自
其中变量R1至R7,m,n,
如本文所定义。
还提供了一种利用上述化合物治疗上述疾病的方法。